• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX RX25 OXYGENATOR/RESERVOIR (LF PORT); OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX RX25 OXYGENATOR/RESERVOIR (LF PORT); OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*RX25RW
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/18/2016
Event Type  malfunction  
Manufacturer Narrative
The actual device was discarded by the involved facility and the lot number is unknown, however the facility provided photos of the involved device for evaluation.Based on the photos provided it was observed that some film-like clots had formed inside the lower part of the venous reservoir.The production lot number was not provided by the user facility, which prevented a meaningful review of the device history record and complaint files.With no return of the actual sample, the cause cannot be definitively determined.There are many complex clinical variables that may have caused the reported observed conditions.However, there is no indication that the reported event was related to a product malfunction or defect.The device labeling does address the potential for such an event in the instruction for use (ifu) "adequate heparinization of the blood is required to prevent it from clotting in the system.Do not reduce heparin during circulation.Otherwise, blood clotting might occur." (b)(4).All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported a clot while using the capiox rx25 device.Follow up communication with the user facility confirmed the following information: during a few recent cases such horizontal blood clots were seen at the outer side of the venous filter; the procedure was completed successfully; and there was no patient impact.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX RX25 OXYGENATOR/RESERVOIR (LF PORT)
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key5662378
MDR Text Key45433520
Report Number9681834-2016-00119
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350769572
UDI-Public04987350769572
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
K040210
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 05/18/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberCX*RX25RW
Was Device Available for Evaluation? No
Date Manufacturer Received04/25/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-